An innovative avenue in the battle against chronic pain

12/03/18

News 

Neuropathic pain is a chronic disease that affects 7 to 10% of the French population and for which there is currently no effective treatment. Researchers from the Institute for Neurosciences of Montpellier (Inserm/University of Montpellier) and the Laboratory for Therapeutic Innovation (CNRS/University of Strasbourg) have now successfully identified the mechanism that gives rise to and continues to cause this pain. Thanks to this discovery, they have developed an innovative treatment prototype. When tested on animals, it had an immediate and long-lasting therapeutic effect on painful symptoms. This study was published on 12th March 2018 in Nature Communications.

Établissement associé de l'Université de Strasbourg
Fondation Université de Strasbourg
Investissements d'Avenir
Ligue européenne des universités de recherche (LERU)
EUCOR, Le Campus européen
CNRS
Inserm Grand Est
HRS4R